Biomarin Pharmaceutical Inc BMRN:NASDAQ

Last Price$74.85Cboe Real-Time Last Sale as of 10:37AM ET 10/18/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-1.04(1.37%)
Bid (Size)$74.64 (200)
Ask (Size)$75.01 (100)
Day Low / High$74.73 - 75.81
Volume198.2 K

Sector Update: Health Care Stocks Flat To Lower Pre-Bell Tuesday

9:15AM ET 9/07/2021 MT Newswires
Health care stocks were flat to lower pre-bell Tuesday. The iShares NASDAQ Biotechnology Index (IBB) was inactive while the Health Care SPDR (XLV) was down 0.04% in recent trading.

BioMarin Pharmaceutical (BMRN) was slipping past 8% after saying the US Food and Drug Administration has placed its phase 1/2 trial of BMN 307 gene therapy in adults with phenylketonuria, a type of genetic disorder, on clinical hold following interim safety data from a pre-clinical study in mice.

Adaptimmune Therapeutics (ADAP) was rallying past 24% after saying it entered into a strategic collaboration and license agreement with Genentech to develop and commercialize allogeneic cell therapies for the treatment of multiple oncology indications.

TransMedics Group (TMDX) was gaining nearly 4% after saying the US Food and Drug Administration has granted premarket approval of its OCS Heart System for use with organs from donors after brain death.